Advanced Cell Technology, Inc.

Read the original here:
ACT Announces that Additional Patient with Stargardt’s Disease Has Undergone Embryonic Stem Cell Transplantation at …

Advanced Cell Technology, Inc. , a leader in the field of regenerative medicine, today announced treatment of the first patient in its Phase 1/2 clinical trial for Stargardt’s macular dystrophy using retinal pigment epithelial cells derived from human embryonic stem cells .

Follow this link:
ACT Announces Europe’s First Human Embryonic Stem Cell Transplant in Patient with Stargardt’s Disease

British medical researchers have condemned a Europe-wide ban on the patenting of stem cell inventions derived from human embryos – setting back possible new treatments for a range of disorders, from heart disease and diabetes to blindness and Parkinson’s.

Originally posted here:
Medicine thrown into crisis by stem cell ruling

LONDON — Europe’s top court says patents cannot be filed on stem-cell research using cells from human embryos, a move many scientists say will harm future advances in medicine.

Read more here:
Europe’s top court bans scientists from stem cell patents, experts say research will suffer

Europe’s top court says patents cannot be filed on stem-cell research using cells from human embryos, a move many scientists say will harm future advances in medicine.

Read more here:
Europe’s top court bans stem cell patents

The company announced earlier in November that the federal government awarded them nearly $1 million in grant money for their embryo-destroying research, thanks to the Patient Protection and Affordable Care Act (PPACA), …

Follow this link:
Feds approve human embryo stem cell trial for ObamaCare-funded …